The patient is also considered to be low risk if the tumor is an intrathyroidal encapsulated follicular variant of papillary thyroid cancer, an intrathyroidal, well-differentiated follicular thyroid carcinoma with capsular invasion and absent or minimal (less than four foci) vascular invasion, or an intrathyroidal papillary microcarcinoma that is unifocal or multifocal, including tumors with a BRAF V600E mutation (if the mutation status is known). This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.